Patient perspective on psoriasis: Psychosocial burden of psoriasis and its management in Malaysia
PLOS ONE · 18.07.2024 · 19 (7) · e0305870
DOI: 10.1371/journal.pone.0305870 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 18.07.2024. Verfasst von Azura Mohd Affandi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Consultant Dermatologist, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Psoriasis, Quality of Life. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johnson & Johnson.
Abstract (Originalsprache)
Background
Psoriasis is a chronic erythematous inflammatory skin disorder. The major challenge with psoriasis is delayed diagnosis, resulting in delayed treatment initiation and reduced quality of life (QoL).
Objective
This patient perspective study aimed to explore the emotional and psychosocial burdens faced by patients with psoriasis in Malaysia and their attitudes toward current psoriasis treatment.
Methods
Adult patients with mild or moderate-to-severe plaque psoriasis, preferably with concomitant psoriatic arthritis, participated in a patient advisory board meeting along with a senior consultant dermatologist. Patients had to describe their initial symptoms, time of diagnosis, misdiagnosis, treatment initiation delays, treatment course, flare-ups, psychosocial impact, and QoL associated with psoriasis.
Results
The 11 participating patients had a mean age of 46 years with mean age of psoriasis diagnosis and an average year of suffering with psoriasis being 21.9 years and 24.5 years, respectively. The most common initial symptom of psoriasis was itching (62.5%), particularly of the scalp followed by itchiness and red patches on skin. Most patients (90%) reported initial misdiagnosis with other skin diseases by their primary care physicians (PCPs), which led to delayed treatment initiation. Most patients reported an emotional impact of psoriasis, including low self-esteem (18%), lack of confidence (27%), shock (18%), sadness (9%), and outrage (9%). Social discrimination/stigmatization in public places and at work (45%), and even from relatives (18%) was another reported challenge. However, 73% of patients were highly satisfied with the current treatment. Overall, the patients agreed that the lack of public awareness of psoriasis was responsible for the social stigma.
Conclusions
The evidence obtained from this qualitative study indicated that psoriasis has a significant emotional and psychological impact on the patients affecting their QoL. Lack of awareness of the disease among PCPs, patients, and the public is a major challenge leading to poor treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Consultant Dermatologist, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.
- Medical Advisor of Psoriasis Association of Malaysia, Selangor Darul Ehsan, Malaysia.
- Psoriasis Association of Malaysia, Selangor Darul Ehsan, Malaysia.
ORCID-Profile: Azura Mohd Affandi
Förderung
- Johnson & Johnson
Zitieren
APA
Affandi, A. M., & Thiruchelvam, K. (2024). Patient perspective on psoriasis: Psychosocial burden of psoriasis and its management in Malaysia. PLOS ONE, 19(7), e0305870. https://doi.org/10.1371/journal.pone.0305870
Vancouver
Affandi AM, Thiruchelvam K. Patient perspective on psoriasis: Psychosocial burden of psoriasis and its management in Malaysia. PLOS ONE. 2024;19(7):e0305870. doi:10.1371/journal.pone.0305870
BibTeX
@article{Affandi2024,
author = {Affandi, Azura Mohd and Thiruchelvam, K},
title = {Patient perspective on psoriasis: Psychosocial burden of psoriasis and its management in Malaysia},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {7},
pages = {e0305870},
doi = {10.1371/journal.pone.0305870}
}
EUVIMED